BioSpace News Archive

AIM ImmunoTech Inc. announced the successfully completion of cGMP manufacturing of 9,042 clinical vials of Ampligen®, AIM’s dsRNA product candidate being developed for globally important cancers, viral diseases and disorders of the immune system.

CorMedix Inc. today announced that it will report its financial results for the first quarter ended March 31, 2024, before the market opens on Thursday, May 9, 2024, and will host a corporate update conference call at 8:30am Eastern Time.

Allogene Therapeutics, Inc. today announced that it will report first quarter 2024 financial results and provide a business update on May 13, 2024, after the close of the market.

TC BioPharm PLC announced the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell therapies for the treatment of refractory cancers and solid tumors.

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression.

Neurocrine Biosciences, Inc. today renewed its commitment to increasing awareness and advancing care for people living with TD during Tardive Dyskinesia Awareness Week, May 5-11.

Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones.

Myomo, Inc. announced that the Centers for Medicare & Medicaid Services, through their regional contractors known as the DME MACs, have remitted and paid lump sum reimbursements to the Company and are beginning to reimburse orthotics and prosthetics providers for MyoPros delivered to Medicare Part B beneficiaries.

Jaguar Health, Inc. announced that it has established a new Investigational New Animal Drug file with the Center for Veterinary Medicine of the U.S. Food and Drug Administration for the company’s novel plant-based prescription drug crofelemer to treat general, non-infectious diarrhea in dogs.

BostonGene and the Medical College of Wisconsin, announced the manuscript “Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for PDAC’’ has published online and in print in Gastroenterology, the premier journal in the field of gastrointestinal disease.